137 related articles for article (PubMed ID: 37657236)
41. Aberrant frequency of TNFR2
Zhang T; Jiao J; Jiao X; Zhao L; Tian X; Zhang Q; Ma D; Cui B
Oncotarget; 2018 Jan; 9(4):5073-5083. PubMed ID: 29435163
[TBL] [Abstract][Full Text] [Related]
42. Differential role of TNFR1 and TNFR2 in the development of imiquimod-induced mouse psoriasis.
Chen S; Lin Z; Xi L; Zheng Y; Zhou Q; Chen X
J Leukoc Biol; 2021 Dec; 110(6):1047-1055. PubMed ID: 34494306
[TBL] [Abstract][Full Text] [Related]
43. Blockade of TNF-α/TNFR2 signalling suppresses colorectal cancer and enhances the efficacy of anti-PD1 immunotherapy by decreasing CCR8+ T regulatory cells.
Guo Y; Xie F; Liu X; Ke S; Chen J; Zhao Y; Li N; Wang Z; Yi G; Shen Y; Li D; Zhu C; Zhang Z; Zhao G; Lu H; Li B; Zhao W
J Mol Cell Biol; 2023 Nov; ():. PubMed ID: 37935468
[TBL] [Abstract][Full Text] [Related]
44. Decreased suppression of CD8
Giri PS; Dwivedi M; Begum R
Exp Dermatol; 2020 Aug; 29(8):759-775. PubMed ID: 32682346
[TBL] [Abstract][Full Text] [Related]
45. Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4
He T; Yang D; Li XQ; Jiang M; Islam MS; Chen S; Chen Y; Yang Y; Chou CK; Trivett AL; Oppenheim JJ; Chen X
Sci Adv; 2020 Sep; 6(40):. PubMed ID: 32998896
[TBL] [Abstract][Full Text] [Related]
46. Regulation of CD4⁺FOXP3⁺ T cells by CCL20/CCR6 axis in early unexplained recurrent miscarriage patients.
Zhang XX; Kang XM; Zhao AM
Genet Mol Res; 2015 Aug; 14(3):9145-54. PubMed ID: 26345847
[TBL] [Abstract][Full Text] [Related]
47. IL-1R1 is expressed on both Helios(+) and Helios(-) FoxP3(+) CD4(+) T cells in the rheumatic joint.
Müller M; Herrath J; Malmström V
Clin Exp Immunol; 2015 Oct; 182(1):90-100. PubMed ID: 26076982
[TBL] [Abstract][Full Text] [Related]
48. T regulatory cells in cord blood--FOXP3 demethylation as reliable quantitative marker.
Liu J; Lluis A; Illi S; Layland L; Olek S; von Mutius E; Schaub B
PLoS One; 2010 Oct; 5(10):e13267. PubMed ID: 20967272
[TBL] [Abstract][Full Text] [Related]
49. Frequently Increased but Functionally Impaired CD4+CD25+ Regulatory T Cells in Patients with Oral Lichen Planus.
Zhou L; Cao T; Wang Y; Yao H; Du G; Chen G; Niu X; Tang G
Inflammation; 2016 Jun; 39(3):1205-15. PubMed ID: 27106476
[TBL] [Abstract][Full Text] [Related]
50. A profile of TNFR2
Azid NA; Ahmad S; Boer JC; Al-Hatamleh MAI; Mohammad N; Mohd Ashari NS; Tan HT; Chen X; Plebanski M; Mohamud R
Hum Immunol; 2020; 81(10-11):634-643. PubMed ID: 32771274
[TBL] [Abstract][Full Text] [Related]
51. TNF-TNFR2 Signal Plays a Decisive Role in the Activation of CD4
Islam MS; Yang Y; Chen X
Adv Exp Med Biol; 2021; 1278():257-272. PubMed ID: 33523452
[TBL] [Abstract][Full Text] [Related]
52. Distribution, characterization, and induction of CD8+ regulatory T cells and IL-17-producing CD8+ T cells in nasopharyngeal carcinoma.
Li J; Huang ZF; Xiong G; Mo HY; Qiu F; Mai HQ; Chen QY; He J; Chen SP; Zheng LM; Qian CN; Zeng YX
J Transl Med; 2011 Nov; 9():189. PubMed ID: 22051182
[TBL] [Abstract][Full Text] [Related]
53. Distepharinamide, a novel dimeric proaporphine alkaloid from Diploclisia glaucescens, inhibits the differentiation and proliferative expansion of CD4
Chen FY; Geng CA; Chou CK; Zheng JB; Yang Y; Wang YF; Li TZ; Li P; Chen JJ; Chen X
Phytomedicine; 2022 Dec; 107():154482. PubMed ID: 36202057
[TBL] [Abstract][Full Text] [Related]
54. The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4
He T; Liu S; Chen S; Ye J; Wu X; Bian Z; Chen X
Front Immunol; 2018; 9():1556. PubMed ID: 30038619
[TBL] [Abstract][Full Text] [Related]
55. Optimizing TNFR2 antagonism for immunotherapy with tumor microenvironment specificity.
Yang M; Tran L; Torrey H; Song Y; Perkins H; Case K; Zheng H; Takahashi H; Kuhtreiber WM; Faustman DL
J Leukoc Biol; 2020 Jun; 107(6):971-980. PubMed ID: 32202358
[TBL] [Abstract][Full Text] [Related]
56. An immunocytokine consisting of a TNFR2 agonist and TNFR2 scFv enhances the expansion of regulatory T cells through TNFR2 clustering.
Inoue M; Tsuji Y; Kashiwada A; Yokoyama A; Iwata A; Abe Y; Kamada H; Tsunoda SI
Biochem Biophys Res Commun; 2024 Feb; 697():149498. PubMed ID: 38262291
[TBL] [Abstract][Full Text] [Related]
57. Lenalidomide-based maintenance therapy reduces TNF receptor 2 on CD4 T cells and enhances immune effector function in acute myeloid leukemia patients.
Govindaraj C; Madondo M; Kong YY; Tan P; Wei A; Plebanski M
Am J Hematol; 2014 Aug; 89(8):795-802. PubMed ID: 24757092
[TBL] [Abstract][Full Text] [Related]
58. TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function.
Nagar M; Jacob-Hirsch J; Vernitsky H; Berkun Y; Ben-Horin S; Amariglio N; Bank I; Kloog Y; Rechavi G; Goldstein I
J Immunol; 2010 Apr; 184(7):3570-81. PubMed ID: 20181891
[TBL] [Abstract][Full Text] [Related]
59. Modulation of Regulatory T Cell Activity by TNF Receptor Type II-Targeting Pharmacological Agents.
Zou H; Li R; Hu H; Hu Y; Chen X
Front Immunol; 2018; 9():594. PubMed ID: 29632537
[TBL] [Abstract][Full Text] [Related]
60. Expression of CD4+CD25+CD127
Zhou W; Deng J; Chen Q; Li R; Xu X; Guan Y; Li W; Xiong X; Li H; Li J; Cai X
Int J Med Sci; 2020; 17(6):712-719. PubMed ID: 32218692
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
